PURE Bioscience Gets $2.376M In PIPE

San Diego-based PURE Bioscience, a publicly held developer of antimicrobial compounds, said today that it has raised $2.376M in a private placement. Name of the investors were not disclosed. The firm said it sold 1,080,000 new shares of its stock at $2.20 per share. The firm said the new funding will go towards working capital.